Literature DB >> 22689073

Evaluation of the endothelial function in hypertensive patients with 13N-ammonia PET.

Erick Alexánderson1, Rodrigo Jácome, Moisés Jiménez-Santos, Juan Manuel Ochoa, Edgar Romero, Marco Antonio Peña Cabral, Alejandro Ricalde, Fernando Iñarra, Aloha Meave, Graciela Alexánderson.   

Abstract

BACKGROUND: Essential hypertension is one of the main risk factors for the development of coronary artery disease (CAD). Hypertension causes endothelial dysfunction which is considered an early sign for the development of CAD. Positron emission tomography is a non-invasive imaging technique that measures myocardial blood flow (MBF), allowing us to identify patients with endothelial dysfunction. METHODS AND
RESULTS: 19 patients without comorbidities recently diagnosed hypertensive, as well as 21 healthy volunteers were studied. A three-phase (rest, cold pressor test, and adenosine-induced hyperemia) (13)N-ammonia PET was performed, and MBF was measured. Endothelial-Dependent Vasodilation Index, ΔMBF, and coronary flow reserve (CFR) were calculated for each patient. Hypertensive patients had a significantly higher systolic and diastolic blood pressures compared with the control group (134.6 ± 11.7/86.4 ± 10.6 mm Hg and 106.0 ± 11.8/71.4 ± 6.6 mm Hg, respectively, P < .001). The ENDEVI (1.28 ± 0.26 vs 1.79 ± 0.30, P < .001), the ΔMBF (0.81 ± 0.50 vs 0.25 ± 0.21, P < .001) and the CFR (2.18 ± 0.88 vs 3.17 ± 0.68, P = .001) were significantly lower in the hypertensive patients compared to the control group, 84% of the former group had endothelial dysfunction i.e., ENDEVI < 1.5 and 58% had vasomotor abnormalities, i.e., CFR < 2.5.
CONCLUSIONS: In this study, we showed that recently diagnosed hypertensive patients have coronary endothelial dysfunction and vasomotor disturbances which are early signs for the development of CAD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689073     DOI: 10.1007/s12350-012-9584-z

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  34 in total

Review 1.  Reactive oxygen species and vascular remodelling in hypertension: still alive.

Authors:  Shaoping Xu; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

2.  Endothelial dysfunction in patients with antiphospholipid syndrome assessed with positron emission tomography.

Authors:  Erick Alexanderson; Patricio Cruz; Angélica Vargas; Aloha Meave; Alejandro Ricalde; Jose A Talayero; José Luis Romero-Ibarra; Tovë M Goldson; Olga L Vera-Lastra; Gabriela Medina; Luis Jara; Mary-Carmen Amigo
Journal:  J Nucl Cardiol       Date:  2007-07-02       Impact factor: 5.952

Review 3.  Positron emission tomography/computed tomography: the current technology and applications.

Authors:  Erik Mittra; Andrew Quon
Journal:  Radiol Clin North Am       Date:  2009-01       Impact factor: 2.303

4.  Evaluation of coronary blood flow reserve by 13N-NH3 positron emission computed tomography (PET) with dipyridamole in the treatment of hypertension with the ACE inhibitor (Cilazapril).

Authors:  D Masuda; R Nohara; N Tamaki; R Hosokawa; H Inada; T Hikai; L G Chen; E Tadamura; T Kudou; J Konishi; M Fujita; S Sasayama
Journal:  Ann Nucl Med       Date:  2000-10       Impact factor: 2.668

5.  Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans.

Authors:  John O Prior; Thomas H Schindler; Alvaro D Facta; Miguel Hernandez-Pampaloni; Roxana Campisi; Magnus Dahlbom; Heinrich R Schelbert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-11       Impact factor: 9.236

Review 6.  Clinical myocardial perfusion PET/CT.

Authors:  Marcelo F Di Carli; Sharmila Dorbala; Jolene Meserve; Georges El Fakhri; Arkadiusz Sitek; Stephen C Moore
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin.

Authors:  M Guethlin; A M Kasel; K Coppenrath; S Ziegler; W Delius; M Schwaiger
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

Review 9.  NADPH oxidases: functions and pathologies in the vasculature.

Authors:  Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

10.  Early impairment of coronary flow reserve in young men with borderline hypertension.

Authors:  H Laine; O T Raitakari; H Niinikoski; O P Pitkänen; H Iida; J Viikari; P Nuutila; J Knuuti
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

View more
  8 in total

1.  Myocardial perfusion reserve in spared myocardium: one more tessera of the complex mosaic of LV remodelling after myocardial infarction.

Authors:  Raffaele Giubbini; Francesco Bertagna
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08       Impact factor: 9.236

2.  Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

Authors:  Venkatesh L Murthy; Timothy M Bateman; Rob S Beanlands; Daniel S Berman; Salvador Borges-Neto; Panithaya Chareonthaitawee; Manuel D Cerqueira; Robert A deKemp; E Gordon DePuey; Vasken Dilsizian; Sharmila Dorbala; Edward P Ficaro; Ernest V Garcia; Henry Gewirtz; Gary V Heller; Howard C Lewin; Saurabh Malhotra; April Mann; Terrence D Ruddy; Thomas H Schindler; Ronald G Schwartz; Piotr J Slomka; Prem Soman; Marcelo F Di Carli; Andrew Einstein; Raymond Russell; James R Corbett
Journal:  J Nucl Cardiol       Date:  2018-02       Impact factor: 5.952

3.  Impact of time-of-flight on qualitative and quantitative analyses of myocardial perfusion PET studies using (13)N-ammonia.

Authors:  Takeshi Tomiyama; Keiichi Ishihara; Masaya Suda; Koji Kanaya; Minoru Sakurai; Naoto Takahashi; Hitoshi Takano; Koichi Nitta; Kenta Hakozaki; Shin-ichiro Kumita
Journal:  J Nucl Cardiol       Date:  2014-12-03       Impact factor: 5.952

4.  Patients with reduced heart rate response to adenosine infusion have low myocardial flow reserve in (13)N-ammonia PET studies.

Authors:  Takeshi Tomiyama; Shin-ichiro Kumita; Keiichi Ishihara; Masaya Suda; Minoru Sakurai; Kenta Hakozaki; Hidenobu Hashimoto; Naoto Takahashi; Hitoshi Takano; Yasuhiro Kobayashi; Tomonari Kiriyama; Yoshimitsu Fukushima; Wataru Shimizu
Journal:  Int J Cardiovasc Imaging       Date:  2015-04-07       Impact factor: 2.357

Review 5.  Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging.

Authors:  Adam A Ghotbi; Andreas Kjaer; Philip Hasbak
Journal:  Clin Physiol Funct Imaging       Date:  2013-09-13       Impact factor: 2.273

Review 6.  Advanced tracers in PET imaging of cardiovascular disease.

Authors:  Yesen Li; Wei Zhang; Hua Wu; Gang Liu
Journal:  Biomed Res Int       Date:  2014-10-15       Impact factor: 3.411

7.  β2-adrenergic stress evaluation of coronary endothelial-dependent vasodilator function in mice using (11)C-acetate micro-PET imaging of myocardial blood flow and oxidative metabolism.

Authors:  Etienne Croteau; Jennifer M Renaud; Christine Archer; Ran Klein; Jean N DaSilva; Terrence D Ruddy; Rob Sb Beanlands; Robert A deKemp
Journal:  EJNMMI Res       Date:  2014-12-16       Impact factor: 3.138

8.  Uridine Adenosine Tetraphosphate-Induced Coronary Relaxation Is Blunted in Swine With Pressure Overload: A Role for Vasoconstrictor Prostanoids.

Authors:  Zhichao Zhou; Inge M Lankhuizen; Heleen M van Beusekom; Caroline Cheng; Dirk J Duncker; Daphne Merkus
Journal:  Front Pharmacol       Date:  2018-03-26       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.